Latest News and Press Releases
Want to stay updated on the latest news?
-
Trial to be conducted at UCLA and funded by a grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA)First phase of trial will enroll up to 30 children ages 8 – 12 with exposure to...
-
LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases,...
-
The S. Mark Taper Foundation has gifted $1.250 million to name the Dining Room at the Westside Los Angeles Ronald McDonald House.
-
PharmAla completes historic first shipment of MDMA from Canada to USA for use in a UCLA Clinical Trial
-
Pacific Software Inc. appoints Dr. Robert Schiestl as Chief Science Advisor to enhance their Dermatrix technology and dietary supplements.
-
Brera Holdings (Nasdaq: BREA) appoints Dicey Perrine, former UCLA Volleyball MVP, as the Head of its US Operations
-
San Diego, CA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- JLab today announced a comprehensive college sports program that will support 17 D1 schools along with student athletes across men’s and women’s...
-
LOS ANGELES, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment...
-
LOS ANGELES, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment...
-
LOS ANGELES, June 27, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment...